Status:
COMPLETED
Pancreatitis - Microbiome As Predictor of Severity
Lead Sponsor:
University Medical Center Goettingen
Collaborating Sponsors:
Department of Medicine II, University Hospital Rostock
Medical Department II, Division of Gastroenterology, University Hospital of Leipzig
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study is a multicentric prospective study initiated and coordinated from the University Medical Centre Goettingen. The study aims to evaluate the orointestinal microbiome as a potential biomarker...
Detailed Description
This prospective translational study aims to evaluate the orointestinal microbiome as a potential biomarker for the course, severity and outcome of patients with acute pancreatitis. From each patient ...
Eligibility Criteria
Inclusion
- Patients with acute pancreatitis (2 out of 3 following diagnostic criteria: lipase \>3x of upper limit, abdominal pain, and imaging modalities (computed tomography, magnetic resonance imaging or ultrasound).
- \< 72 hours after hospital admission.
Exclusion
- Pregnant women Patients \< 18 years; Patients who are incapable of giving consent
Key Trial Info
Start Date :
February 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2024
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT04777812
Start Date
February 17 2020
End Date
February 23 2024
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Göttingen
Göttingen, Germany, 37075